Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine H Kin, AJ Zatta, MT Lofye, BS Amerson, ME Halkos, F Kerendi, ZQ Zhao, ... Cardiovascular research 67 (1), 124-133, 2005 | 522 | 2005 |
Mice Lacking the Vascular Endothelial Growth Factor-B Gene (Vegfb) Have Smaller Hearts, Dysfunctional Coronary Vasculature, and Impaired Recovery From … D Bellomo, JP Headrick, GU Silins, CA Paterson, PS Thomas, M Gartside, ... Circulation research 86 (2), e29-e35, 2000 | 490 | 2000 |
Cardiovascular adenosine receptors: expression, actions and interactions JP Headrick, KJ Ashton, RB Rose'Meyer, JN Peart Pharmacology & therapeutics 140 (1), 92-111, 2013 | 278 | 2013 |
Estrogen improves biochemical and neurologic outcome following traumatic brain injury in male rats, but not in females CS Emerson, JP Headrick, R Vink Brain research 608 (1), 95-100, 1993 | 232 | 1993 |
Adenosinergic cardioprotection: multiple receptors, multiple pathways JN Peart, JP Headrick Pharmacology & therapeutics 114 (2), 208-221, 2007 | 225 | 2007 |
Acute adenosinergic cardioprotection in ischemic-reperfused hearts JP Headrick, B Hack, KJ Ashton American Journal of Physiology-Heart and Circulatory Physiology 285 (5 …, 2003 | 225 | 2003 |
Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia GP Matherne, J Linden, AM Byford, NS Gauthier, JP Headrick Proceedings of the National Academy of Sciences 94 (12), 6541-6546, 1997 | 221 | 1997 |
Loss of caveolin-1 accelerates neurodegeneration and aging BP Head, JN Peart, M Panneerselvam, T Yokoyama, ML Pearn, ... PloS one 5 (12), e15697, 2010 | 198 | 2010 |
Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine JP Headrick Journal of molecular and cellular cardiology 28 (6), 1227-1240, 1996 | 179 | 1996 |
Opioid receptors and cardioprotection–‘opioidergic conditioning’of the heart JP Headrick, LE See Hoe, EF Du Toit, JN Peart British journal of pharmacology 172 (8), 2026-2050, 2015 | 177 | 2015 |
Adenosine and its receptors in the heart: regulation, retaliation and adaptation JP Headrick, JN Peart, ME Reichelt, LJ Haseler Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (5), 1413-1428, 2011 | 168 | 2011 |
Age-related changes in ischemic tolerance in male and female mouse hearts L Willems, A Zatta, K Holmgren, KJ Ashton, JP Headrick Journal of molecular and cellular cardiology 38 (2), 245-256, 2005 | 133 | 2005 |
Adenosine receptors and reperfusion injury of the heart JP Headrick, RD Lasley Adenosine receptors in health and disease, 189-214, 2009 | 131 | 2009 |
Endothelium-dependent and-independent relaxations to adenosine in guinea pig aorta JP Headrick, RM Berne American Journal of Physiology-Heart and Circulatory Physiology 259 (1), H62-H67, 1990 | 124 | 1990 |
Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia–reperfusion K Venardos, G Harrison, J Headrick, A Perkins Journal of Trace Elements in Medicine and Biology 18 (1), 81-88, 2004 | 121 | 2004 |
Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts JN Peart, ER Gross, ME Reichelt, A Hsu, JP Headrick, GJ Gross Basic research in cardiology 103, 454-463, 2008 | 119 | 2008 |
Clinical cardioprotection and the value of conditioning responses JN Peart, JP Headrick American Journal of Physiology-Heart and Circulatory Physiology 296 (6 …, 2009 | 117 | 2009 |
Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection JN Peart, ER Gross, JP Headrick, GJ Gross Journal of molecular and cellular cardiology 42 (5), 972-980, 2007 | 96 | 2007 |
Ischaemic Tolerance in Aged Mouse Myocardium: The Role of Adenosine and Effects of A1 Adenosine Receptor Overexpression JP Headrick, L Willems, KJ Ashton, K Holmgren, J Peart, GP Matherne The Journal of physiology 549 (3), 823-833, 2003 | 94 | 2003 |
Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart J Peart, A Flood, J Linden, GP Matherne, JP Headrick Journal of cardiovascular pharmacology 39 (1), 117-129, 2002 | 92 | 2002 |